Can the innate immune system be reprogrammed to fight cancer? Inmune Bio believes the answer is yes.
Stephanie Sutton | | Quick Read
There are two parts to the human immune system: adaptive and innate. There are many therapies designed to improve the adaptive immune response against cancer (for example, vaccines, CAR-T cells and immune checkpoint inhibitors), but far fewer efforts focus on boosting the innate immune system response to cancer. According to Inmune Bio CEO, RJ Tesi, if medical practitioners only have access to therapies targeting the adaptive immune system then it’s like trying to fight with just one hand... Tesi wants to bring the innate immune system into the ring. We asked him more about the company’s research.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.